Have a personal or library account? Click to login
Investigation of Fasciculation and Elongation Protein ζ-1 (FEZ1) in Peripheral Blood Reveals Differences in Gene Expression in Patients with Schizophrenia Cover

Investigation of Fasciculation and Elongation Protein ζ-1 (FEZ1) in Peripheral Blood Reveals Differences in Gene Expression in Patients with Schizophrenia

Open Access
|Dec 2015

References

  1. 1. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007; 64(1): 19-28.10.1001/archpsyc.64.1.19
  2. 2. Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi Le, Arinami T, et al. Meta analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry. 2009; 14(8): 774-785.10.1038/mp.2008.135
  3. 3. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009; 460(7256): 753-757.10.1038/nature08192
  4. 4. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature. 2009; 460(7256): 744-747.10.1038/nature08186
  5. 5. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 460(7256): 748-752.10.1038/nature08185
  6. 6. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W, et al. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res. 2004; 67(1): 41-52.10.1016/S0920-9964(03)00151-8
  7. 7. Kuzman MR, Medved V, Terzic J, Krainc D. Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia. J Psychiatr Res. 2009; 43(13): 1073-1037.10.1016/j.jpsychires.2009.03.00519358997
  8. 8. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, Fujita T, et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry. 2003; 8(7): 685-694.10.1038/sj.mp.400135212874605
  9. 9. Lipska BK, Peters T, Hyde TM, Halim N, Horowitz C, Mitkus T, et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum Mol Genet. 2006; 15(8): 1245-1258.10.1093/hmg/ddl04016510495
  10. 10. Sakae N, Yamasaki N, Kitaichi K, Fukuda T, Yamada M, Yoshikawa H, et al. Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. Hum Mol Genet. 2008; 17(20): 3191-3203.10.1093/hmg/ddn21518647754
  11. 11. Moens LN, de Rijk P, Reumers J, van den Bossche MJ, Glassee W, de Zutter S, et al. Sequencing of DISC1 pathway genes reveals increased burden of rare missense variants in schizophrenia patients from a Northern Swedish population. PLoS ONE. 2011; 6(8): e23450. doi: 10.1371/ journal.pone.0023450.10.1371/journal.pone.0023450315493921853134
  12. 12. Chubb JE, Bradshaw NJ, Soares DC, Poeteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol Psychiatry. 2008; 13(1): 36-64.10.1038/sj.mp.400210617912248
  13. 13. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006; 15(21): 3132-3145.10.1093/hmg/ddl253279994316984965
  14. 14. Wang J, Robinson JF, Khan HM, Carter DE, McKinney J, Miskie BA, et al. Optimizing RNA extraction yield from whole blood for microarray gene expression analysis. Clin Biochem. 2004; 37(9): 741-744.10.1016/j.clinbiochem.2004.03.01315329310
  15. 15. Yu Z, Ono C, Kim HB, Komatsu H, Tanabe Y, Sakae N, et al. Four mood stabilizers commonly induce FEZ1 expression in human astrocytes. Bipolar Disord. 2011; 13(5-6): 486-499.10.1111/j.1399-5618.2011.00946.x22017218
  16. 16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) method. Methods. 2001; 25(4): 402-408.10.1006/meth.2001.126211846609
  17. 17. Austin CP, Ky B, Ma L, Morris JA, Shughrue PJ. Expression of disrupted-in-Schizophrenia-1, a schizophre-nia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience. 2004; 124(1): 3-10.10.1016/j.neuroscience.2003.11.01014960334
  18. 18. Honda A, Miyoshi K, Baba K, Taniguchi M, Koyama Y, Kuroda S, et al. Expression of fasciculation and elongation protein zeta-1 (FEZ1) in the developing rat brain. Brain Res Mol Brain Res. 2004; 122(1): 89-92.10.1016/j.molbrainres.2003.11.02014992819
  19. 19. Koga M, Ishiguro H, Horiuchi Y, Albalushi T, Inada T, Iwata N, et al. Failure to confirm the association between the FEZ1 gene and schizophrenia in a Japanese population. Neurosci. Lett. 2007; 417(3): 326-329.
  20. 20. Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari MR, Ahmadkhaniha H, Thiagalingam S, et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res. 2011; 45(11): 1432-1438. 10.1016/j.jpsychires.2011.06.01321820670
Language: English
Page range: 31 - 38
Published on: Dec 30, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2015 T.I. Vachev, V.K. Stoyanova, H.Y. Ivanov, I.N. Minkov, N.T. Popov, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.